Usher Syndrome Type 2 clinical trials at UCSF
1 studies in progress, 0 open to new patients

This clinical trial is a single-site, 30 patient study for participants who have early stage retinitis pigmentosa, or Usher syndrome (type 2 or 3). Funding Source - FDA OOPD and Foundation Fighting Blindness.